{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:04:21Z","timestamp":1793257461528,"version":"4.5.0"},"reference-count":205,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL123920"],"award-info":[{"award-number":["HL123920"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL137093"],"award-info":[{"award-number":["HL137093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL144002"],"award-info":[{"award-number":["HL144002"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL146153"],"award-info":[{"award-number":["HL146153"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL147357"],"award-info":[{"award-number":["HL147357"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL149940"],"award-info":[{"award-number":["HL149940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18TPA34230092"],"award-info":[{"award-number":["18TPA34230092"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["19EIA34660286"],"award-info":[{"award-number":["19EIA34660286"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.addr.2021.03.021","type":"journal-article","created":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T17:54:23Z","timestamp":1617645263000},"page":"504-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":352,"special_numbering":"C","title":["Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies"],"prefix":"10.1016","volume":"173","author":[{"given":"Mengrui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"L\u00f3pez de Juan Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2021.03.021_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00777","article-title":"The processes and mechanisms of cardiac and pulmonary fibrosis","volume":"8","author":"Murtha","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.addr.2021.03.021_b0010","first-page":"E38","article-title":"Amer Heart Assoc Stat, S. Stroke Stat, Heart disease and stroke statistics-2016 update a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2021.03.021_b0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"Porter","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.addr.2021.03.021_b0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2010.02.047","article-title":"Assessment of nonischemic myocardial fibrosis","volume":"56","author":"Jellis","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0025","doi-asserted-by":"crossref","first-page":"11352","DOI":"10.1021\/acs.chemrev.8b00323","article-title":"Nanoscale technologies for prevention and treatment of heart failure: challenges and opportunities","volume":"119","author":"Hajipour","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2021.03.021_b0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2018.10.007","article-title":"Crosslinked self-assembled nanoparticles for chemo-sonodynamic combination therapy favoring antitumor, antimetastasis management and immune responses","volume":"290","author":"Liu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2021.03.021_b0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.colsurfb.2015.12.049","article-title":"Recent progresses in bioadhesive microspheres via transmucosal administration","volume":"140","author":"Jiao","year":"2016","journal-title":"Colloids Surf. B-Biointerfaces"},{"key":"10.1016\/j.addr.2021.03.021_b0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2017.07.010","article-title":"Drug targeting to myofibroblasts: implications for fibrosis and cancer","volume":"121","author":"Yazdani","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.03.021_b0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.118.256156","article-title":"Targeted drug delivery to hepatic stellate cells for the treatment of liver fibrosis","volume":"370","author":"Chen","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2021.03.021_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-020-00836-6","article-title":"Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis","author":"Hu","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2021.03.021_b0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2019.01.032","article-title":"Drug delivery systems targeting tumor-associated fibroblasts for cancer immunotherapy","volume":"448","author":"Liu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2021.03.021_b0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1158\/0008-5472.CAN-16-0866","article-title":"Targeting tumor-associated fibroblasts for therapeutic delivery in desmoplastic tumors","volume":"77","author":"Miao","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2021.03.021_b0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.biomaterials.2015.10.010","article-title":"Nanoparticle-enhanced generation of gene-transfected mesenchymal stem cells for in vivo cardiac repair","volume":"74","author":"Zhu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.03.021_b0070","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/adhm.201600088","article-title":"Nano-enabled approaches for stem cell-based cardiac tissue engineering","volume":"5","author":"Kharaziha","year":"2016","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.addr.2021.03.021_b0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.03.021_b0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.119.315491","article-title":"Generation of quiescent cardiac fibroblasts from human induced pluripotent stem cells for in vitro modeling of cardiac fibrosis","volume":"125","author":"Zhang","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","article-title":"Myofibroblast-mediated mechanisms of pathological remodelling of the heart","volume":"10","author":"Weber","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","article-title":"Fibrosis and heart failure","volume":"19","author":"Segura","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.addr.2021.03.021_b0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cardiores.2004.06.006","article-title":"Matricellular proteins in the heart: possible role during stress and remodeling","volume":"64","author":"Schellings","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0100","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCRESAHA.114.302533","article-title":"Myocardial extracellular matrix an ever-changing and diverse entity","volume":"114","author":"Rienks","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tcm.2017.01.011","article-title":"Myocardial fibrosis predicts ventricular tachyarrhythmias","volume":"27","author":"Disertori","year":"2017","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","article-title":"Cardiac fibrosis - A short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2021.03.021_b0115","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00059-012-3719-5","article-title":"Diastolic heart failure: what we still don't know Looking for new concepts, diagnostic approaches, and the role of comorbidities","volume":"37","author":"Tschoepe","year":"2012","journal-title":"Herz"},{"key":"10.1016\/j.addr.2021.03.021_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6050053","article-title":"The soft-and hard-heartedness of cardiac fibroblasts: mechanotransduction signaling pathways in fibrosis of the heart","volume":"6","author":"Herum","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5453606","article-title":"Imaging of myocardial fibrosis in patients with end-stage renal disease: current limitations and future possibilities","volume":"2017","author":"Graham-Brown","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.addr.2021.03.021_b0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/FJC.0b013e318207a35f","article-title":"Fibrosis and cardiac arrhythmias","volume":"57","author":"de Jong","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.addr.2021.03.021_b0135","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2021.03.021_b0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/jmcc.1993.1021","article-title":"Alteration of cardiac collagen phenotypes in hypertensive hypertrophy - role of blood-pressure","volume":"25","author":"Mukherjee","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0145","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI115414","article-title":"Alteration of collagen phenotypes in ischemic cardiomyopathy","volume":"88","author":"Mukherjee","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2021.03.021_b0150","doi-asserted-by":"crossref","first-page":"H323","DOI":"10.1152\/ajpheart.00321.2005","article-title":"Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling, American journal of physiology","volume":"290","author":"Naugle","year":"2006","journal-title":"Heart Circ. Physiol."},{"key":"10.1016\/j.addr.2021.03.021_b0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.yjmcc.2008.10.022","article-title":"Cardiac myofibroblast differentiation is attenuated by alpha(3) integrin blockade: potential role in post-MI remodeling","volume":"46","author":"Bryant","year":"2009","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0160","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCRESAHA.111.252734","article-title":"Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarction","volume":"110","author":"Luther","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.addr.2021.03.021_b0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.matbio.2018.03.016","article-title":"Biomechanical and biomolecular characterization of extracellular matrix structures in human colon carcinomas","volume":"68\u201369","author":"Brauchle","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2020.06.030","article-title":"Type V collagen in scar tissue regulates the size of scar after heart injury","volume":"182","author":"Yokota","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.addr.2021.03.021_b0175","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1096\/fj.201902692R","article-title":"Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1\/miR-141-mediated NLRP3 inflammasome and TGF-\u03b21\/Smads signaling in diabetic cardiomyopathy","volume":"34","author":"Che","year":"2020","journal-title":"FASEB J.: Off. Publ. Feder. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020360","article-title":"Dual role of triptolide in interrupting the NLRP3 inflammasome pathway to attenuate cardiac fibrosis","volume":"20","author":"Pan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2021.03.021_b0185","doi-asserted-by":"crossref","first-page":"7269150","DOI":"10.1155\/2020\/7269150","article-title":"The role of autophagy and NLRP3 inflammasome in liver fibrosis","volume":"2020","author":"Tao","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.addr.2021.03.021_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000941","article-title":"YAP\/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction","volume":"18","author":"Mia","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41420-020-00316-9","article-title":"Mitochondrial dysfunction in fibrotic diseases","volume":"6","author":"Li","year":"2020","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.addr.2021.03.021_b0200","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.redox.2015.09.005","article-title":"Reactive oxygen species and mitochondria: a nexus of cellular homeostasis","volume":"6","author":"Dan Dunn","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0205","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.addr.2021.03.021_b0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:HREV.0000011393.40674.13","article-title":"Regulation of matrix metalloproteinases by cytokines and reactive oxygen\/nitrogen species in the myocardium","volume":"9","author":"Siwik","year":"2004","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.addr.2021.03.021_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006247","article-title":"The microRNA-29\/PGC1\u03b1 regulatory axis is critical for metabolic control of cardiac function","volume":"16","author":"Caravia","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2014.02.004","article-title":"CaMKII oxidative activation and the pathogenesis of cardiac disease","volume":"73","author":"Luczak","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184374","article-title":"CaMKII activity in the inflammatory response of cardiac diseases","volume":"20","author":"Rusciano","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2021.03.021_b0230","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","article-title":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure","volume":"108","author":"Dai","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101100","article-title":"Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice","volume":"21","author":"Goh","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0240","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ajhg.2016.06.027","article-title":"Sudden cardiac death due to deficiency of the mitochondrial inorganic pyrophosphatase PPA2","volume":"99","author":"Kennedy","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.addr.2021.03.021_b0245","first-page":"940","article-title":"Endoplasmic reticulum stress as a pro-fibrotic stimulus","volume":"2013","author":"Tanjore","year":"1832","journal-title":"BBA"},{"key":"10.1016\/j.addr.2021.03.021_b0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cbi.2014.10.032","article-title":"Attenuation of ER stress prevents post-infarction-induced cardiac rupture and remodeling by modulating both cardiac apoptosis and fibrosis","volume":"225","author":"Luo","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.addr.2021.03.021_b0255","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.trsl.2014.05.001","article-title":"Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities","volume":"164","author":"Cavalera","year":"2014","journal-title":"Transl. Res.: J. Lab. Clin. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0260","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2021.03.021_b0265","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0270","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1159\/000495969","article-title":"Targeting PPAR\u03b1 for the treatment and understanding of cardiovascular diseases","volume":"51","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol."},{"key":"10.1016\/j.addr.2021.03.021_b0275","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","article-title":"Epithelial-mesenchymal transition and its implications for fibrosis","volume":"112","author":"Kalluri","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2021.03.021_b0280","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ar.a.10129","article-title":"The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells","volume":"276","author":"Wessels","year":"2004","journal-title":"Anatom. Rec. Part A, Discov. Mol., Cell., Evolut. Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1420.005","article-title":"Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin","volume":"1123","author":"Norris","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2021.03.021_b0295","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.110.938217","article-title":"Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition","volume":"121","author":"Widyantoro","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2021.03.021_b0300","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","article-title":"Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis","volume":"16","author":"Kramann","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2021.03.021_b0305","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue-repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0310","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/path.2281","article-title":"Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction","volume":"214","author":"van Amerongen","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2021.03.021_b0315","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12265-012-9402-7","article-title":"Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts","volume":"5","author":"Crawford","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0320","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.1073\/pnas.0608799103","article-title":"Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice","volume":"103","author":"Haudek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.addr.2021.03.021_b0325","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.03.021_b0330","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.copbio.2003.08.006","article-title":"Mechanisms of force generation and transmission by myofibroblasts","volume":"14","author":"Hinz","year":"2003","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.addr.2021.03.021_b0335","doi-asserted-by":"crossref","first-page":"H1871","DOI":"10.1152\/ajpheart.00387.2003","article-title":"Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts","volume":"285","author":"Wang","year":"2003","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.addr.2021.03.021_b0340","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1083\/jcb.142.3.873","article-title":"The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta 1","volume":"142","author":"Serini","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0345","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5084","article-title":"BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure","volume":"9","author":"Duan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tcm.2006.11.001","article-title":"Smoothelin in vascular smooth muscle cells","volume":"17","author":"van Eys","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0355","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0002-9440(10)63847-3","article-title":"Global expression profiling of fibroblast responses to transforming growth factor-beta(1) reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching","volume":"162","author":"Chambers","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2021.03.021_b0360","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1038\/sj.jid.5700427","article-title":"Isoform-specific regulation of the actin-organizing protein palladin during TGF-ss 1-induced myofibroblast differentiation","volume":"126","author":"Ronty","year":"2006","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.03.021_b0365","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1091\/mbc.12.10.3060","article-title":"Characterization of human palladin, a microfilament-associated protein","volume":"12","author":"Mykkanen","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.addr.2021.03.021_b0370","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCRESAHA.120.317685","article-title":"Multiscale analysis of extracellular matrix remodeling in the failing heart","volume":"128","author":"Perestrelo","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0375","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1586\/14779072.2016.1147348","article-title":"Myofibroblast secretome and its auto-\/paracrine signaling","volume":"14","author":"Bomb","year":"2016","journal-title":"Expert Rev. Cardiovasc. Therapy"},{"key":"10.1016\/j.addr.2021.03.021_b0380","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0008-6363(00)00032-8","article-title":"Infarct scar: a dynamic tissue","volume":"46","author":"Sun","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0385","doi-asserted-by":"crossref","first-page":"C910","DOI":"10.1152\/ajpcell.1995.268.4.C910","article-title":"Norepinephrine and ang ii stimulate secretion of tgf-beta by neonatal rat cardiac fibroblasts in-vitro","volume":"268","author":"Fisher","year":"1995","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"10.1016\/j.addr.2021.03.021_b0390","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1242\/jcs.114.24.4359","article-title":"Smad regulation in TGF-beta signal transduction","volume":"114","author":"Moustakas","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.addr.2021.03.021_b0395","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/FJC.0b013e31820cda19","article-title":"The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts","volume":"57","author":"Vasquez","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.addr.2021.03.021_b0400","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2019.00318","article-title":"Cardiac fibroblasts and cardiac fibrosis: precise role of exosomes","volume":"7","author":"Ranjan","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0405","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.yjmcc.2015.10.022","article-title":"A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes","volume":"89","author":"Lyu","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0410","first-page":"4350","article-title":"Exosomes derived from cardiomyocytes promote cardiac fibrosis via myocyte-fibroblast cross-talk","volume":"10","author":"Yang","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0415","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jcmm.12218","article-title":"Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes","volume":"18","author":"Chen","year":"2014","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0420","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.7150\/thno.22878","article-title":"MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress","volume":"8","author":"Yuan","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2021.03.021_b0425","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1096\/fj.201701455RR","article-title":"Cardiac fibroblast-specific p38\u03b1 MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism","volume":"32","author":"Bageghni","year":"2018","journal-title":"FASEB J.: Off. Publ. Feder. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0430","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.7150\/thno.48787","article-title":"Low-density lipoprotein receptor-related protein 6 regulates cardiomyocyte-derived paracrine signaling to ameliorate cardiac fibrosis","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2021.03.021_b0435","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-019-0269-4","article-title":"Macrophages in cardiac repair: Environmental cues and therapeutic strategies","volume":"51","author":"de Couto","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0440","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymthe.2016.09.001","article-title":"Macrophage-derived mir-155-containing exosomes suppress fibroblast proliferation and promote fibroblast inflammation during cardiac injury","volume":"25","author":"Wang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.03.021_b0445","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1802-2","article-title":"An acute immune response underlies the benefit of cardiac stem cell therapy","volume":"577","author":"Vagnozzi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.03.021_b0450","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.addr.2021.03.021_b0455","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.03.021_b0460","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s13238-017-0402-x","article-title":"Molecular barriers to direct cardiac reprogramming","volume":"8","author":"Vaseghi","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.addr.2021.03.021_b0465","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.03.021_b0470","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCRESAHA.116.305547","article-title":"Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming","volume":"116","author":"Wang","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089678","article-title":"Inhibition of TGFbeta signaling increases direct conversion of fibroblasts to induced cardiomyocytes","volume":"9","author":"Ifkovits","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.03.021_b0480","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1038\/ncomms9243","article-title":"High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling","volume":"6","author":"Zhao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.03.021_b0485","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.stemcr.2015.10.019","article-title":"Fibroblast growth factors and vascular endothelial growth factor promote cardiac reprogramming under defined conditions","volume":"5","author":"Yamakawa","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2021.03.021_b0490","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13287-017-0569-3","article-title":"Direct reprogramming of fibroblasts into cardiomyocytes","volume":"8","author":"Chen","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.addr.2021.03.021_b0495","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCRESAHA.109.200451","article-title":"Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure","volume":"105","author":"Rao","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0500","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3892\/mmr.2017.6282","article-title":"MicroRNA-1 upregulation promotes myocardiocyte proliferation and suppresses apoptosis during heart development","volume":"15","author":"Liu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2021.03.021_b0505","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.15252\/embj.201387605","article-title":"MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures","volume":"33","author":"Muraoka","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2021.03.021_b0510","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCRESAHA.112.269035","article-title":"MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes","volume":"110","author":"Jayawardena","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0515","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCRESAHA.116.304510","article-title":"MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function","volume":"116","author":"Jayawardena","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0520","article-title":"Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.03.021_b0525","doi-asserted-by":"crossref","first-page":"1403-+","DOI":"10.1161\/CIRCRESAHA.116.308741","article-title":"Demethylation of H3K27 is essential for the induction of direct cardiac reprogramming by miR combo","volume":"120","author":"Dal-Pra","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0530","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2021.03.021_b0535","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201705134","article-title":"Dual-drug delivery using dextran-functionalized nanoparticles targeting cardiac fibroblasts for cellular reprogramming","volume":"28","author":"Ferreira","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2021.03.021_b0540","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1021\/acsanm.9b02586","article-title":"Poly(lactic-co-glycolic acid)\/polyethylenimine nanocarriers for direct genetic reprogramming of MicroRNA targeting cardiac fibroblasts","volume":"3","author":"Muniyandi","year":"2020","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.addr.2021.03.021_b0545","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.1301019110","article-title":"Reprogramming of human fibroblasts toward a cardiac fate","volume":"110","author":"Nam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.addr.2021.03.021_b0550","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.1304053110","article-title":"Induction of human cardiomyocyte-like cells from fibroblasts by defined factors","volume":"110","author":"Wada","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.addr.2021.03.021_b0555","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.stemcr.2013.07.005","article-title":"Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state","volume":"1","author":"Fu","year":"2013","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2021.03.021_b0560","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.stem.2014.01.006","article-title":"Small molecules facilitate the reprogramming of mouse fibroblasts into pancreatic lineages","volume":"14","author":"Li","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2021.03.021_b0565","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/cr.2013.156","article-title":"Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells","volume":"24","author":"Zhu","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.addr.2021.03.021_b0570","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.celrep.2014.01.038","article-title":"Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4","volume":"6","author":"Wang","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.addr.2021.03.021_b0575","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.aaf1502","article-title":"Conversion of human fibroblasts into functional cardiomyocytes by small molecules","volume":"352","author":"Cao","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.03.021_b0580","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1242\/dev.114025","article-title":"Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors","volume":"141","author":"Nam","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.addr.2021.03.021_b0585","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/cvr\/cvt167","article-title":"Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain","volume":"100","author":"Hirai","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0590","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/cvr\/cvu023","article-title":"Inhibitors of suppressive histone modification promote direct reprogramming of fibroblasts to cardiomyocyte-like cells","volume":"102","author":"Hirai","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089678","article-title":"Inhibition of TGF beta signaling increases direct conversion of fibroblasts to induced cardiomyocytes","volume":"9","author":"Ifkovits","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.03.021_b0600","first-page":"1841","article-title":"Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells","volume":"10","author":"Lee","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2021.03.021_b0605","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9243","article-title":"High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling","volume":"6","author":"Zhao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.03.021_b0610","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1016\/j.biomaterials.2013.05.050","article-title":"Direct reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogels","volume":"34","author":"Smith","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.03.021_b0615","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yjmcc.2013.04.004","article-title":"Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success","volume":"60","author":"Addis","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0620","doi-asserted-by":"crossref","unstructured":"T.M. Jayawardena, E.A. Finch, L. Zhang, H. Zhang, C.P. Hodgkinson, R.E. Pratt, P.B. Rosenberg, M. Mirotsou, V.J. Dzau, MicroRNA induced cardiac reprogramming in vivo evidence for mature cardiac myocytes and improved cardiac function, Circ. Res. 116 (2015) 418.","DOI":"10.1161\/CIRCRESAHA.116.304510"},{"key":"10.1016\/j.addr.2021.03.021_b0625","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/cr.2015.99","article-title":"Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails","volume":"25","author":"Fu","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.addr.2021.03.021_b0630","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbrc.2015.05.127","article-title":"Ascorbic acid promotes the direct conversion of mouse fibroblasts into beating cardiomyocytes","volume":"463","author":"Talkhabi","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2021.03.021_b0635","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.1304053110","article-title":"Induction of human cardiomyocyte-like cells from fibroblasts by defined factors","volume":"110","author":"Wada","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.addr.2021.03.021_b0640","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.1301019110","article-title":"Reprogramming of human fibroblasts toward a cardiac fate","volume":"110","author":"Nam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.addr.2021.03.021_b0645","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1089\/hum.2009.146","article-title":"T cell receptor gene therapy for cancer","volume":"20","author":"Schmitt","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2021.03.021_b0650","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.03.021_b0655","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005568","article-title":"Cell-based therapeutics: the next pillar of medicine","volume":"5","author":"Fischbach","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0660","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.20130110","article-title":"Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia","volume":"210","author":"Tran","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0665","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","article-title":"Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0670","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-14-3041","article-title":"Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells","volume":"75","author":"Lo","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2021.03.021_b0675","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCRESAHA.118.311217","article-title":"Clinical studies of cell therapy in cardiovascular medicine: recent developments and future directions","volume":"123","author":"Banerjee","year":"2018","journal-title":"Circ Res"},{"issue":"2016","key":"10.1016\/j.addr.2021.03.021_b0680","first-page":"831","article-title":"Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review","volume":"1","author":"Nguyen","year":"2000","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0685","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/01.CIR.0000085305.82019.65","article-title":"Stem cell repair of infarcted myocardium: an overview for clinicians","volume":"108","author":"Forrester","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2021.03.021_b0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122377","article-title":"Intrapericardial administration of mesenchymal stem cells in a large animal model: a bio-distribution analysis","volume":"10","author":"Blazquez","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.03.021_b0695","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00059-010-3382-7","article-title":"Intrapericardial procedures for cardiac regeneration by stem cells: need for minimal invasive access (AttachLifter) to the normal pericardial cavity","volume":"35","author":"Rupp","year":"2010","journal-title":"Herz"},{"key":"10.1016\/j.addr.2021.03.021_b0700","doi-asserted-by":"crossref","unstructured":"F. Fernandez-Aviles, R. Sanz-Ruiz, A.M. Climent, L. Badimon, R. Bolli, D. Charron, V. Fuster, S. Janssens, J. Kastrup, H.S. Kim, T.F. Luscher, J.F. Martin, P. Menasche, R.D. Simari, G.W. Stone, A. Terzic, J.T. Willerson, J.C. Wu, T.W. Group, C. Authors\/Task Force Members, S. Basic Research, S. Translational Research, S. Challenges of Cardiovascular Regenerative Medicine, S. Tissue Engineering, N.T. Delivery, S. Assessment, S. Clinical Trials, Regulatory, s. funding strategies, N.T. Delivery, S. Assessment, Global position paper on cardiovascular regenerative medicine, Eur. Heart J., 38 (2017) 2532\u20132546.","DOI":"10.1093\/eurheartj\/ehx248"},{"key":"10.1016\/j.addr.2021.03.021_b0705","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.03.021_b0710","first-page":"1","article-title":"Adjuvant role of macrophages in stem cell-induced cardiac repair in rats","volume":"50","author":"Lim","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0715","doi-asserted-by":"crossref","unstructured":"M. Liu, H. Lutz, D. Zhu, K. Huang, Z. Li, P.C. Dinh, J. Gao, Y. Zhang, K. Cheng, Bispecific Antibody Inhalation Therapy for Redirecting Stem Cells from the Lungs to Repair Heart Injury, Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany), 8 (2020) 2002127.","DOI":"10.1002\/advs.202002127"},{"key":"10.1016\/j.addr.2021.03.021_b0720","doi-asserted-by":"crossref","first-page":"33088","DOI":"10.1021\/acsami.8b13571","article-title":"Cardiac stem cell patch integrated with microengineered blood vessels promotes cardiomyocyte proliferation and neovascularization after acute myocardial infarction","volume":"10","author":"Su","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2021.03.021_b0725","doi-asserted-by":"crossref","first-page":"9738","DOI":"10.1021\/acsnano.7b01008","article-title":"Heart repair using nanogel-encapsulated human cardiac stem cells in mice and pigs with myocardial infarction","volume":"11","author":"Tang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2021.03.021_b0730","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.1073\/pnas.1505405112","article-title":"Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery","volume":"112","author":"Yu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.addr.2021.03.021_b0735","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.addr.2003.10.023","article-title":"Microneedles for transdermal drug delivery","volume":"56","author":"Prausnitz","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.03.021_b0740","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nmat4249","article-title":"Biodegradable silicon nanoneedles delivering nucleic acids intracellularly induce localized in vivo neovascularization","volume":"14","author":"Chiappini","year":"2015","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2021.03.021_b0745","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat9365","article-title":"Cardiac cell-integrated microneedle patch for treating myocardial infarction","volume":"4","author":"Tang","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2021.03.021_b0750","article-title":"Engineered cell-degradable poly(2-alkyl-2-oxazoline) hydrogel for epicardial placement of mesenchymal stem cells for myocardial repair","author":"You","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.03.021_b0755","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820941323","article-title":"Synergistic fabrication of dose-response chitosan\/dextran\/beta-glycerophosphate injectable hydrogel as cell delivery carrier for cardiac healing after acute myocardial infarction","volume":"18","author":"Hua","year":"2020","journal-title":"Dose-Response"},{"key":"10.1016\/j.addr.2021.03.021_b0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.111789","article-title":"Human mesenchymal stem cells encapsulated-coacervated photoluminescent nanodots layered bioactive chitosan\/collagen hydrogel matrices to indorse cardiac healing after acute myocardial infarction","volume":"206","author":"Si","year":"2020","journal-title":"J. Photochem. Photobiol. B-Biol."},{"key":"10.1016\/j.addr.2021.03.021_b0765","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/ten.tea.2010.0124","article-title":"Transplantation of Marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction","volume":"17","author":"Guo","year":"2011","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.addr.2021.03.021_b0770","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41551-017-0182-x","article-title":"Targeted repair of heart injury by stem cells fused with platelet nanovesicles","volume":"2","author":"Tang","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.addr.2021.03.021_b0775","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1021\/acsnano.8b05892","article-title":"Pretargeting and bioorthogonal click chemistry-mediated endogenous stem cell homing for heart repair","volume":"12","author":"Li","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2021.03.021_b0780","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefrancais","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.03.021_b0785","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1536-y","article-title":"Stem cell-derived cell sheet transplantation for heart tissue repair in myocardial infarction","volume":"11","author":"Guo","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.addr.2021.03.021_b0790","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1021\/acsbiomaterials.0c00942","article-title":"Cardiac stromal cell patch integrated with engineered microvessels improves recovery from myocardial infarction in rats and pigs","volume":"6","author":"Su","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.addr.2021.03.021_b0795","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1021\/acs.nanolett.8b04970","article-title":"Antibody-armed platelets for the regenerative targeting of endogenous stem cells","volume":"19","author":"Shen","year":"2019","journal-title":"Nano Lett"},{"key":"10.1016\/j.addr.2021.03.021_b0800","article-title":"Bispecific antibody therapy for effective cardiac repair through redirection of endogenous stem cells","volume":"2","author":"Huang","year":"2019","journal-title":"Adv. Therap."},{"key":"10.1016\/j.addr.2021.03.021_b0805","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1161\/CIRCULATIONAHA.110.009993","article-title":"Induced adipocyte cell-sheet ameliorates cardiac dysfunction in a mouse myocardial infarction model: a novel drug delivery system for heart failure","volume":"124","author":"Imanishi","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2021.03.021_b0810","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/ten.tec.2016.0492","article-title":"A regenerative cardiac patch formed by spray painting of biomaterials onto the heart","volume":"23","author":"Tang","year":"2017","journal-title":"Tissue Eng. Part C: Methods"},{"key":"10.1016\/j.addr.2021.03.021_b0815","unstructured":"<Ke huang Sience translational.pdf>."},{"key":"10.1016\/j.addr.2021.03.021_b0820","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCRESAHA.116.310374","article-title":"Fabrication of synthetic mesenchymal stem cells for the treatment of acute myocardial infarction in mice","volume":"120","author":"Luo","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0825","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13724","article-title":"Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome","volume":"8","author":"Tang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.03.021_b0830","article-title":"Platelet-inspired nanocells for targeted heart repair after ischemia\/reperfusion injury","volume":"29","author":"Su","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2021.03.021_b0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120168","article-title":"Monocyte mimics improve mesenchymal stem cell-derived extracellular vesicle homing in a mouse MI\/RI model","volume":"255","author":"Zhang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.03.021_b0840","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvz139","article-title":"Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19","volume":"116","author":"Huang","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0845","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.coph.2016.01.003","article-title":"Stem cells and exosomes in cardiac repair","volume":"27","author":"Singla","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.addr.2021.03.021_b0850","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-020-00675-6","article-title":"Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis","volume":"18","author":"Yan","year":"2020","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/j.addr.2021.03.021_b0855","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvt338","article-title":"Reversible and irreversible differentiation of cardiac fibroblasts","volume":"101","author":"Driesen","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0860","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nmat4780","article-title":"MicroRNA-21 preserves the fibrotic mechanical memory of mesenchymal stem cells","volume":"16","author":"Li","year":"2017","journal-title":"Nat Mater"},{"key":"10.1016\/j.addr.2021.03.021_b0865","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3317\/jraas.2005.006","article-title":"Angiotensin II receptor blockade and ventricular remodelling","volume":"6","author":"Anavekar","year":"2005","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.addr.2021.03.021_b0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2005.06.007","article-title":"Activation of protein kinase A by atrial natriuretic peptide in neonatal rat cardiac fibroblasts: Role in regulation of the local renin-angiotensin system","volume":"132","author":"Sanghi","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.addr.2021.03.021_b0875","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-beta(1) and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0880","doi-asserted-by":"crossref","DOI":"10.1097\/00004872-200401000-00031","article-title":"Collagen production in cardiac fibroblasts during inhibition of angiotensin converting enzyme and aminopeptidases","volume":"22","author":"Lijnen","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.addr.2021.03.021_b0885","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijcard.2007.08.134","article-title":"Imidaprilat inhibits matrix metalloproteinase-2 activity in human cardiac fibroblasts induced by interleukin-1 beta via NO-dependent pathway","volume":"126","author":"Guo","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0890","first-page":"6043","article-title":"Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1\/AT2 receptors and ACEACE2 in rats","volume":"9","author":"Pang","year":"2015","journal-title":"Drug Design Dev. Therapy"},{"key":"10.1016\/j.addr.2021.03.021_b0895","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cardiores.2004.07.020","article-title":"Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin","volume":"64","author":"Porter","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0900","doi-asserted-by":"crossref","first-page":"H1738","DOI":"10.1152\/ajpheart.00341.2006","article-title":"Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone","volume":"291","author":"Chen","year":"2006","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.addr.2021.03.021_b0905","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10517-007-0015-0","article-title":"Effect of pravastatin on phenotypical transformation of fibroblasts and hypertrophy of cardiomyocytes in culture","volume":"143","author":"Moiseeva","year":"2007","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.addr.2021.03.021_b0910","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2005.11.014","article-title":"Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications","volume":"45","author":"Touyz","year":"2006","journal-title":"Vasc.Pharmacol."},{"key":"10.1016\/j.addr.2021.03.021_b0915","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.03.021_b0920","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCRESAHA.119.315125","article-title":"Dynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation","volume":"125","author":"Stratton","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2021.03.021_b0925","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1039\/C9TB02523E","article-title":"An injectable thermosensitive hydrogel loaded with an ancient natural drug colchicine for myocardial repair after infarction","volume":"8","author":"Chen","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2021.03.021_b0930","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fphar.2017.00186","article-title":"A clinical perspective of anti-fibrotic therapies for cardiovascular disease","volume":"8","author":"Fang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2021.03.021_b0935","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","article-title":"Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2021.03.021_b0940","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FJC.0b013e3181d70690","article-title":"Candesartan decreases type III procollagen-N-peptide levels and inflammatory marker levels and maintains sinus rhythm in patients with atrial fibrillation","volume":"55","author":"Kawamura","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.addr.2021.03.021_b0945","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jcmg.2011.08.014","article-title":"A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome","volume":"4","author":"Kosmala","year":"2011","journal-title":"JACC. Cardiovasc. Imag."},{"key":"10.1016\/j.addr.2021.03.021_b0950","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cardfail.2011.04.007","article-title":"Results of the randomized aldosterone antagonism in heart failure with preserved ejection fraction trial (RAAM-PEF)","volume":"17","author":"Deswal","year":"2011","journal-title":"J. Cardiac Fail."},{"key":"10.1016\/j.addr.2021.03.021_b0955","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jchf.2013.09.001","article-title":"Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy","volume":"1","author":"Shimada","year":"2013","journal-title":"JACC. Heart Failure"},{"key":"10.1016\/j.addr.2021.03.021_b0960","first-page":"320","article-title":"Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade","volume":"99","author":"Kosmala","year":"2013","journal-title":"Heart (British Cardiac Society)"},{"key":"10.1016\/j.addr.2021.03.021_b0965","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clinthera.2011.11.002","article-title":"Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide","volume":"34","author":"Abulhul","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.addr.2021.03.021_b0970","first-page":"798","article-title":"Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study","volume":"92","author":"Prasad","year":"2006","journal-title":"Heart (British Cardiac Society)"},{"key":"10.1016\/j.addr.2021.03.021_b0975","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"L\u00f3pez","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0980","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2007.04.080","article-title":"Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure","volume":"50","author":"L\u00f3pez","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2021.03.021_b0985","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/HYPERTENSIONAHA.108.125278","article-title":"Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure","volume":"53","author":"L\u00f3pez","year":"2009","journal-title":"Hypertension (Dallas Tex.: 1979)"},{"key":"10.1016\/j.addr.2021.03.021_b0990","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.111.063412","article-title":"Chronic Inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging","volume":"125","author":"Giannetta","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2021.03.021_b0995","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2021.03.021_b1000","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(09)60622-X","article-title":"Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study","volume":"373","author":"Teerlink","year":"2009","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.addr.2021.03.021_b1005","doi-asserted-by":"crossref","DOI":"10.1042\/BST20191255","article-title":"New perspectives of the cardiac cellular landscape: mapping cellular mediators of cardiac fibrosis using single-cell transcriptomics","author":"Krstevski","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.addr.2021.03.021_b1010","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.119.044557","article-title":"Single-cell RNA sequencing analysis reveals a crucial role for CTHRC1 (collagen triple helix repeat containing 1) cardiac fibroblasts after myocardial infarction","volume":"142","author":"Ruiz-Villalba","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2021.03.021_b9000","article-title":"Exosome-eluting stents for vascular healing after ischaemic injury","author":"Hu","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.addr.2021.03.021_b9005","article-title":"Injection of ROS-responsive hydrogel loaded with basic fibroblast growth factor into the pericardial cavity for heart repair","volume":"31","author":"Li","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2021.03.021_b9010","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41467-021-21682-7","article-title":"Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21001009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21001009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:10:54Z","timestamp":1759209054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X21001009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":205,"alternative-id":["S0169409X21001009"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2021.03.021","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2021.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}